The global DNA sequencing market size is expected to reach USD 48.22 billion by 2030, expanding at a CAGR of 21.65% from 2024 to 2030. The incorporation of Artificial Intelligence (AI) has increased the utility of genomic data in clinical practices and thus creates a new frontier in the advancement of genomic data analysis. In May 2020, Nvidia Corporation developed new AI tools, genomic sequencing software, and speech recognition technologies to aid the COVID-19 research efforts. Thus, AI accelerates the variant annotation and prioritization in the clinical diagnosis, which drives the market. ![DNA Sequencing Market]( "DNA Sequencing Market")
Since the completion of the Human Genome Project, the DNA sequencing cost has declined precipitously. The cost of decoding one person’s genome was around USD 50,000 a decade ago and currently has reached nearly USD 600 in the largest genomic centers. Recently, in February 2020, BGI claimed to reduce the cost to sequence the genome to USD 100. This is expected to expand the use of this technology for prenatal tests, cancer screening, and research studies.
With a significant decrease in cost coupled with the availability of funding, several start-ups have entered the market. For instance, in January 2020, Omniome, a startup firm from the U.S., raised USD 60.0 million in Series C financing to speed up the late-stage product development and product launch of its genetic sequencing platform, which consequently fuels market progression.
Since the completion of the Human Genome Project, the DNA sequencing cost has declined precipitously. The cost of decoding one person’s genome was around USD 50,000 a decade ago and currently has reached nearly USD 600 in the largest genomic centers. Recently, in February 2020, BGI claimed to reduce the cost to sequence the genome to USD 100. This is expected to expand the use of this technology for prenatal tests, cancer screening, and research studies.
With a significant decrease in cost coupled with the availability of funding, several start-ups have entered the market. For instance, in January 2020, Omniome, a startup firm from the U.S., raised USD 60.0 million in Series C financing to speed up the late-stage product development and product launch of its genetic sequencing platform, which consequently fuels market progression.
DNA Sequencing Market Report Highlights
- Rise in the availability of services at affordable prices along with consulting services, training courses, and customer support are anticipated to drive the services segment at the fastest growth rate over the forecast period
- Constant technological advancements in third-generation techniques with the launch of new systems are expected to drive this segment at a lucrative CAGR
- For instance, in July 2019, Oxford Nanopore launched GridION Mk1, a benchtop, flexible NGS, data analysis device that improves the performance of the company’s GridION X5 system
- On the basis of workflow, the data analysis step is anticipated to register a considerable CAGR throughout the forecast period
- The advent of workflow management systems with HTS-flow retrieves data from laboratory management systems and manages data analysis through a simple graphical user interface, subsequently streamlining the data analysis workflow
- These technologies are widely accepted in the oncology field to sequence and catalog gene mutations for the development of cancer diagnostic and therapeutics
- A rise in cancer cases globally is driving demand for oncology. It is estimated that there would be nearly 1.8 million new cancer cases in 2020 in the U.S.
- The clinical research segment is projected to witness the fastest growth rate over the forecast period, followed by hospitals and clinics
- Efforts undertaken by companies and government agencies to broaden the accessibility for NGS-based diagnostic tests in the hospitals and diagnostic centers for COVID-19 diagnosis is anticipated to drive the hospitals and clinics segment at a lucrative pace
- In Asia Pacific, the market is expected to progress with the highest CAGR over the forecast period owing to numerous research programs that involve the usage of these tools
- For instance, in October 2019, researchers from the Agency for Science, Technology and Research's Genome Institute of Singapore created the largest genetic databank of Asian populations to support the diagnosis of rare diseases
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product & Service
1.2.2. Technology
1.2.3. Workflow
1.2.4. Application
1.2.5. End-use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. Objectives
1.2. Segment Definitions
1.2.1. Product & Service
1.2.2. Technology
1.2.3. Workflow
1.2.4. Application
1.2.5. End-use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. DNA Sequencing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Technological advancements in sequencing techniques
3.2.1.2. Rising interest in genomics research and personalized medicine
3.2.1.3. Increasing applications of DNA sequencing in clinical diagnostics
3.2.2. Market restraint analysis
3.2.2.1. Data storage and management challenges
3.2.2.2. Ethical and privacy concerns related to the use of sequencing technologies.
3.3. DNA Sequencing Market Analysis Tools
3.3.1. Industry analysis - Porter’s
3.3.2. PESTEL analysis
3.3.3. COVID-19 impact analysis
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Technological advancements in sequencing techniques
3.2.1.2. Rising interest in genomics research and personalized medicine
3.2.1.3. Increasing applications of DNA sequencing in clinical diagnostics
3.2.2. Market restraint analysis
3.2.2.1. Data storage and management challenges
3.2.2.2. Ethical and privacy concerns related to the use of sequencing technologies.
3.3. DNA Sequencing Market Analysis Tools
3.3.1. Industry analysis - Porter’s
3.3.2. PESTEL analysis
3.3.3. COVID-19 impact analysis
Chapter 4. DNA Sequencing Market: Product & Service Estimates & Trend Analysis
4.1. Product & Service Market Share, 2023 & 2030
4.2. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
4.2.1. Consumables
4.2.1.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
4.2.2. Instruments
4.2.2.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
4.2.3. Services
4.2.3.1. Services market estimates and forecasts 2018 to 2030 (USD Million)
4.2. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
4.2.1. Consumables
4.2.1.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
4.2.2. Instruments
4.2.2.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
4.2.3. Services
4.2.3.1. Services market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. DNA Sequencing Market: Technology Estimates & Trend Analysis
5.1. Technology Market Share, 2023 & 2030
5.2. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
5.2.1. Sanger sequencing
5.2.1.1. Sanger sequencing market estimates and forecasts 2018 to 2030 (USD Million)
5.2.2. Next-generation sequencing (NGS)
5.2.2.1. Next-generation sequencing (NGS) market estimates and forecasts 2018 to 2030 (USD Million)
5.2.2.2. Whole genome sequencing (WGS)
5.2.2.2.1. Whole genome sequencing (WGS) market estimates and forecasts 2018 to 2030 (USD Million)
5.2.2.3. Whole exome sequencing (WES)
5.2.2.3.1. Whole exome sequencing (WES) market estimates and forecasts 2018 to 2030 (USD Million)
5.2.2.4. Targeted sequencing & resequencing
5.2.2.4.1. Targeted sequencing & resequencing market estimates and forecasts 2018 to 2030 (USD Million)
5.2.3. Third generation dna sequencing
5.2.3.1. Third generation dna sequencing market estimates and forecasts 2018 to 2030 (USD Million)
5.2.3.2. Single-molecule real-time sequencing (SMRT)
5.2.3.2.1. Single-molecule real-time sequencing (SMRT) market estimates and forecasts 2018 to 2030 (USD Million)
5.2.3.3. Nanopore sequencing
5.2.3.3.1. Nanopore sequencing market estimates and forecasts 2018 to 2030 (USD Million)
5.2. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
5.2.1. Sanger sequencing
5.2.1.1. Sanger sequencing market estimates and forecasts 2018 to 2030 (USD Million)
5.2.2. Next-generation sequencing (NGS)
5.2.2.1. Next-generation sequencing (NGS) market estimates and forecasts 2018 to 2030 (USD Million)
5.2.2.2. Whole genome sequencing (WGS)
5.2.2.2.1. Whole genome sequencing (WGS) market estimates and forecasts 2018 to 2030 (USD Million)
5.2.2.3. Whole exome sequencing (WES)
5.2.2.3.1. Whole exome sequencing (WES) market estimates and forecasts 2018 to 2030 (USD Million)
5.2.2.4. Targeted sequencing & resequencing
5.2.2.4.1. Targeted sequencing & resequencing market estimates and forecasts 2018 to 2030 (USD Million)
5.2.3. Third generation dna sequencing
5.2.3.1. Third generation dna sequencing market estimates and forecasts 2018 to 2030 (USD Million)
5.2.3.2. Single-molecule real-time sequencing (SMRT)
5.2.3.2.1. Single-molecule real-time sequencing (SMRT) market estimates and forecasts 2018 to 2030 (USD Million)
5.2.3.3. Nanopore sequencing
5.2.3.3.1. Nanopore sequencing market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. DNA Sequencing Market: Workflow Estimates & Trend Analysis
6.1. Workflow Market Share, 2023 & 2030
6.2. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.2.1. Pre-sequencing
6.2.1.1. Pre-sequencing market estimates and forecasts 2018 to 2030 (USD Million)
6.2.2. Sequencing
6.2.2.1. Sequencing Market estimates and forecasts 2018 to 2030 (USD Million)
6.2.3. Data Analysis
6.2.3.1. Data analysis Market estimates and forecasts 2018 to 2030 (USD Million)
6.2. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.2.1. Pre-sequencing
6.2.1.1. Pre-sequencing market estimates and forecasts 2018 to 2030 (USD Million)
6.2.2. Sequencing
6.2.2.1. Sequencing Market estimates and forecasts 2018 to 2030 (USD Million)
6.2.3. Data Analysis
6.2.3.1. Data analysis Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. DNA Sequencing Market: Application Estimates & Trend Analysis
7.1. Application Market Share, 2023 & 2030
7.2. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.2.1. Oncology
7.2.1.1. Oncology Market estimates and forecasts 2018 to 2030 (USD Million)
7.2.2. Reproductive Health
7.2.2.1. Reproductive health market estimates and forecasts 2018 to 2030 (USD Million)
7.2.3. Clinical Investigation
7.2.3.1. Clinical investigation Market estimates and forecasts 2018 to 2030 (USD Million)
7.2.4. Agrigenomics & Forensics
7.2.4.1. Agrigenomics & forensics market estimates and forecasts 2018 to 2030 (USD Million)
7.2.5. HLA Typing/Immune System Monitoring
7.2.5.1. HLA Typing/Immune System Monitoring market estimates and forecasts 2018 to 2030 (USD Million)
7.2.6. Metagenomics, Epidemiology, & Drug Development
7.2.6.1. Metagenomics, epidemiology, & drug development market estimates and forecasts 2018 to 2030 (USD Million)
7.2.7. Consumer Genomics
7.2.7.1. Consumer genomics market estimates and forecasts 2018 to 2030 (USD Million)
7.2.8. Others
7.2.8.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
7.2. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.2.1. Oncology
7.2.1.1. Oncology Market estimates and forecasts 2018 to 2030 (USD Million)
7.2.2. Reproductive Health
7.2.2.1. Reproductive health market estimates and forecasts 2018 to 2030 (USD Million)
7.2.3. Clinical Investigation
7.2.3.1. Clinical investigation Market estimates and forecasts 2018 to 2030 (USD Million)
7.2.4. Agrigenomics & Forensics
7.2.4.1. Agrigenomics & forensics market estimates and forecasts 2018 to 2030 (USD Million)
7.2.5. HLA Typing/Immune System Monitoring
7.2.5.1. HLA Typing/Immune System Monitoring market estimates and forecasts 2018 to 2030 (USD Million)
7.2.6. Metagenomics, Epidemiology, & Drug Development
7.2.6.1. Metagenomics, epidemiology, & drug development market estimates and forecasts 2018 to 2030 (USD Million)
7.2.7. Consumer Genomics
7.2.7.1. Consumer genomics market estimates and forecasts 2018 to 2030 (USD Million)
7.2.8. Others
7.2.8.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. DNA Sequencing Market: End-use Estimates & Trend Analysis
8.1. End-use Market Share, 2023 & 2030
8.2. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.2.1. Academic Research
8.2.1.1. Academic research market estimates and forecasts 2018 to 2030 (USD Million)
8.2.2. Clinical Research
8.2.2.1. Clinical research market estimates and forecasts 2018 to 2030 (USD Million)
8.2.3. Hospitals & Clinics
8.2.3.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
8.2.4. Pharmaceutical & Biotechnology Companies
8.2.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
8.2.5. Others
8.2.5.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
8.2. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.2.1. Academic Research
8.2.1.1. Academic research market estimates and forecasts 2018 to 2030 (USD Million)
8.2.2. Clinical Research
8.2.2.1. Clinical research market estimates and forecasts 2018 to 2030 (USD Million)
8.2.3. Hospitals & Clinics
8.2.3.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
8.2.4. Pharmaceutical & Biotechnology Companies
8.2.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
8.2.5. Others
8.2.5.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. DNA Sequencing Market: Regional Estimates & Trend Analysis
9.1. Regional Market Share Analysis, 2023 & 2030
9.2. North America
9.2.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
9.2.2. U.S.
9.2.2.1. Key country dynamics
9.2.2.2. Regulatory framework
9.2.2.3. Target disease prevalence
9.2.2.4. Competitive scenario
9.2.2.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
9.2.3. Canada
9.2.3.1. Key country dynamics
9.2.3.2. Regulatory framework
9.2.3.3. Target disease prevalence
9.2.3.4. Competitive scenario
9.2.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
9.3. Europe
9.3.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
9.3.2. UK
9.3.2.1. Key country dynamics
9.3.2.2. Regulatory framework
9.3.2.3. Target disease prevalence
9.3.2.4. Competitive scenario
9.3.2.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
9.3.3. Germany
9.3.3.1. Key country dynamics
9.3.3.2. Regulatory framework
9.3.3.3. Target disease prevalence
9.3.3.4. Competitive scenario
9.3.3.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
9.3.4. France
9.3.4.1. Key country dynamics
9.3.4.2. Regulatory framework
9.3.4.3. Target disease prevalence
9.3.4.4. Competitive scenario
9.3.4.5. France market estimates and forecasts 2018 to 2030 (USD Million)
9.3.5. Italy
9.3.5.1. Key country dynamics
9.3.5.2. Regulatory framework
9.3.5.3. Target disease prevalence
9.3.5.4. Competitive scenario
9.3.5.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
9.3.6. Spain
9.3.6.1. Key country dynamics
9.3.6.2. Regulatory framework
9.3.6.3. Target disease prevalence k
9.3.6.4. Competitive scenario
9.3.6.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
9.3.7. Norway
9.3.7.1. Key country dynamics
9.3.7.2. Regulatory framework
9.3.7.3. Target disease prevalence
9.3.7.4. Competitive scenario
9.3.7.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
9.3.8. Sweden
9.3.8.1. Key country dynamics
9.3.8.2. Regulatory framework
9.3.8.3. Target disease prevalence
9.3.8.4. Competitive scenario
9.3.8.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
9.3.9. Denmark
9.3.9.1. Key country dynamics
9.3.9.2. Regulatory framework
9.3.9.3. Target disease prevalence
9.3.9.4. Competitive scenario
9.3.9.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
9.4.2. Japan
9.4.2.1. Key country dynamics
9.4.2.2. Regulatory framework
9.4.2.3. Target disease prevalence
9.4.2.4. Competitive scenario
9.4.2.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
9.4.3. China
9.4.3.1. Key country dynamics
9.4.3.2. Regulatory framework
9.4.3.3. Target disease prevalence
9.4.3.4. Competitive scenario
9.4.3.5. China market estimates and forecasts 2018 to 2030 (USD Million)
9.4.4. India
9.4.4.1. Key country dynamics
9.4.4.2. Regulatory framework
9.4.4.3. Target disease prevalence
9.4.4.4. Competitive scenario
9.4.4.5. India market estimates and forecasts 2018 to 2030 (USD Million)
9.4.5. Australia
9.4.5.1. Key country dynamics
9.4.5.2. Regulatory framework
9.4.5.3. Target disease prevalence
9.4.5.4. Competitive scenario
9.4.5.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
9.4.6. South Korea
9.4.6.1. Key country dynamics
9.4.6.2. Regulatory framework
9.4.6.3. Target disease prevalence
9.4.6.4. Competitive scenario
9.4.6.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
9.4.7. Thailand
9.4.7.1. Key country dynamics
9.4.7.2. Regulatory framework
9.4.7.3. Target disease prevalence
9.4.7.4. Competitive scenario
9.4.7.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
9.5. Latin America
9.5.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
9.5.2. Brazil
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework
9.5.2.3. Target disease prevalence
9.5.2.4. Competitive scenario
9.5.2.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
9.5.3. Mexico
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework
9.5.3.3. Target disease prevalence
9.5.3.4. Competitive scenario
9.5.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
9.5.4. Argentina
9.5.4.1. Key country dynamics
9.5.4.2. Regulatory framework
9.5.4.3. Target disease prevalence
9.5.4.4. Competitive scenario
9.5.4.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
9.6. MEA
9.6.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
9.6.2. South Africa
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework
9.6.2.3. Competitive scenario
9.6.2.4. Target disease prevalence
9.6.2.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
9.6.3. Saudi Arabia
9.6.3.1. Key country dynamics
9.6.3.2. Regulatory framework
9.6.3.3. Competitive scenario
9.6.3.4. Target disease prevalence
9.6.3.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
9.6.4. UAE
9.6.4.1. Key country dynamics
9.6.4.2. Regulatory framework
9.6.4.3. Target disease prevalence
9.6.4.4. Competitive scenario
9.6.4.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
9.6.5. Kuwait
9.6.5.1. Key country dynamics
9.6.5.2. Regulatory framework
9.6.5.3. Competitive scenario
9.6.5.4. Target disease prevalence
9.6.5.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
9.2. North America
9.2.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
9.2.2. U.S.
9.2.2.1. Key country dynamics
9.2.2.2. Regulatory framework
9.2.2.3. Target disease prevalence
9.2.2.4. Competitive scenario
9.2.2.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
9.2.3. Canada
9.2.3.1. Key country dynamics
9.2.3.2. Regulatory framework
9.2.3.3. Target disease prevalence
9.2.3.4. Competitive scenario
9.2.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
9.3. Europe
9.3.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
9.3.2. UK
9.3.2.1. Key country dynamics
9.3.2.2. Regulatory framework
9.3.2.3. Target disease prevalence
9.3.2.4. Competitive scenario
9.3.2.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
9.3.3. Germany
9.3.3.1. Key country dynamics
9.3.3.2. Regulatory framework
9.3.3.3. Target disease prevalence
9.3.3.4. Competitive scenario
9.3.3.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
9.3.4. France
9.3.4.1. Key country dynamics
9.3.4.2. Regulatory framework
9.3.4.3. Target disease prevalence
9.3.4.4. Competitive scenario
9.3.4.5. France market estimates and forecasts 2018 to 2030 (USD Million)
9.3.5. Italy
9.3.5.1. Key country dynamics
9.3.5.2. Regulatory framework
9.3.5.3. Target disease prevalence
9.3.5.4. Competitive scenario
9.3.5.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
9.3.6. Spain
9.3.6.1. Key country dynamics
9.3.6.2. Regulatory framework
9.3.6.3. Target disease prevalence k
9.3.6.4. Competitive scenario
9.3.6.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
9.3.7. Norway
9.3.7.1. Key country dynamics
9.3.7.2. Regulatory framework
9.3.7.3. Target disease prevalence
9.3.7.4. Competitive scenario
9.3.7.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
9.3.8. Sweden
9.3.8.1. Key country dynamics
9.3.8.2. Regulatory framework
9.3.8.3. Target disease prevalence
9.3.8.4. Competitive scenario
9.3.8.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
9.3.9. Denmark
9.3.9.1. Key country dynamics
9.3.9.2. Regulatory framework
9.3.9.3. Target disease prevalence
9.3.9.4. Competitive scenario
9.3.9.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
9.4.2. Japan
9.4.2.1. Key country dynamics
9.4.2.2. Regulatory framework
9.4.2.3. Target disease prevalence
9.4.2.4. Competitive scenario
9.4.2.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
9.4.3. China
9.4.3.1. Key country dynamics
9.4.3.2. Regulatory framework
9.4.3.3. Target disease prevalence
9.4.3.4. Competitive scenario
9.4.3.5. China market estimates and forecasts 2018 to 2030 (USD Million)
9.4.4. India
9.4.4.1. Key country dynamics
9.4.4.2. Regulatory framework
9.4.4.3. Target disease prevalence
9.4.4.4. Competitive scenario
9.4.4.5. India market estimates and forecasts 2018 to 2030 (USD Million)
9.4.5. Australia
9.4.5.1. Key country dynamics
9.4.5.2. Regulatory framework
9.4.5.3. Target disease prevalence
9.4.5.4. Competitive scenario
9.4.5.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
9.4.6. South Korea
9.4.6.1. Key country dynamics
9.4.6.2. Regulatory framework
9.4.6.3. Target disease prevalence
9.4.6.4. Competitive scenario
9.4.6.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
9.4.7. Thailand
9.4.7.1. Key country dynamics
9.4.7.2. Regulatory framework
9.4.7.3. Target disease prevalence
9.4.7.4. Competitive scenario
9.4.7.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
9.5. Latin America
9.5.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
9.5.2. Brazil
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework
9.5.2.3. Target disease prevalence
9.5.2.4. Competitive scenario
9.5.2.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
9.5.3. Mexico
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework
9.5.3.3. Target disease prevalence
9.5.3.4. Competitive scenario
9.5.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
9.5.4. Argentina
9.5.4.1. Key country dynamics
9.5.4.2. Regulatory framework
9.5.4.3. Target disease prevalence
9.5.4.4. Competitive scenario
9.5.4.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
9.6. MEA
9.6.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
9.6.2. South Africa
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework
9.6.2.3. Competitive scenario
9.6.2.4. Target disease prevalence
9.6.2.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
9.6.3. Saudi Arabia
9.6.3.1. Key country dynamics
9.6.3.2. Regulatory framework
9.6.3.3. Competitive scenario
9.6.3.4. Target disease prevalence
9.6.3.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
9.6.4. UAE
9.6.4.1. Key country dynamics
9.6.4.2. Regulatory framework
9.6.4.3. Target disease prevalence
9.6.4.4. Competitive scenario
9.6.4.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
9.6.5. Kuwait
9.6.5.1. Key country dynamics
9.6.5.2. Regulatory framework
9.6.5.3. Competitive scenario
9.6.5.4. Target disease prevalence
9.6.5.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company/Competition Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2023
10.4. Company Profiles/Listing
10.4.1. Thermo Fisher Scientific, Inc
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product & service benchmarking
10.4.1.4. Strategic initiatives
10.4.2. Agilent Technology
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product & service benchmarking
10.4.2.4. Strategic initiatives
10.4.3. Illumina, Inc.
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product & service benchmarking
10.4.3.4. Strategic initiatives
10.4.4. QIAGEN
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product & service benchmarking
10.4.4.4. Strategic initiatives
10.4.5. F. Hoffmann-La Roche Ltd.
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product & service benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Oxford Nanopore Technologies plc.
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product & service benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Macrogen, Inc.
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product & service benchmarking
10.4.7.4. Strategic initiatives
10.4.8. PerkinElmer Genomics
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product & service benchmarking
10.4.8.4. Strategic initiatives
10.4.9. PacBio
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product & service benchmarking
10.4.9.4. Strategic initiatives
10.4.10. BGI
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product & service benchmarking
10.4.10.4. Strategic initiatives
10.4.11. Bio-Rad Laboratories, Inc.
10.4.11.1. Company overview
10.4.11.2. Financial performance
10.4.11.3. Product & service benchmarking
10.4.11.4. Strategic initiatives
10.4.12. Myriad Genetics
10.4.12.1. Company overview
10.4.12.2. Financial performance
10.4.12.3. Product & service benchmarking
10.4.12.4. Strategic initiatives
10.4.13. PierianDx
10.4.13.1. Company overview
10.4.13.2. Financial performance
10.4.13.3. Product & service benchmarking
10.4.13.4. Strategic initiatives
10.4.14. Partek Incorporated
10.4.14.1. Company overview
10.4.14.2. Financial performance
10.4.14.3. Product & service benchmarking
10.4.14.4. Strategic initiatives
10.4.15. Eurofins Scientific
10.4.15.1. Company overview
10.4.15.2. Financial performance
10.4.15.3. Product & service benchmarking
10.4.15.4. Strategic initiatives
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2023
10.4. Company Profiles/Listing
10.4.1. Thermo Fisher Scientific, Inc
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product & service benchmarking
10.4.1.4. Strategic initiatives
10.4.2. Agilent Technology
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product & service benchmarking
10.4.2.4. Strategic initiatives
10.4.3. Illumina, Inc.
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product & service benchmarking
10.4.3.4. Strategic initiatives
10.4.4. QIAGEN
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product & service benchmarking
10.4.4.4. Strategic initiatives
10.4.5. F. Hoffmann-La Roche Ltd.
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product & service benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Oxford Nanopore Technologies plc.
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product & service benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Macrogen, Inc.
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product & service benchmarking
10.4.7.4. Strategic initiatives
10.4.8. PerkinElmer Genomics
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product & service benchmarking
10.4.8.4. Strategic initiatives
10.4.9. PacBio
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product & service benchmarking
10.4.9.4. Strategic initiatives
10.4.10. BGI
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product & service benchmarking
10.4.10.4. Strategic initiatives
10.4.11. Bio-Rad Laboratories, Inc.
10.4.11.1. Company overview
10.4.11.2. Financial performance
10.4.11.3. Product & service benchmarking
10.4.11.4. Strategic initiatives
10.4.12. Myriad Genetics
10.4.12.1. Company overview
10.4.12.2. Financial performance
10.4.12.3. Product & service benchmarking
10.4.12.4. Strategic initiatives
10.4.13. PierianDx
10.4.13.1. Company overview
10.4.13.2. Financial performance
10.4.13.3. Product & service benchmarking
10.4.13.4. Strategic initiatives
10.4.14. Partek Incorporated
10.4.14.1. Company overview
10.4.14.2. Financial performance
10.4.14.3. Product & service benchmarking
10.4.14.4. Strategic initiatives
10.4.15. Eurofins Scientific
10.4.15.1. Company overview
10.4.15.2. Financial performance
10.4.15.3. Product & service benchmarking
10.4.15.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Global DNA sequencing market, by region, 2018 - 2030 (USD Million)
Table 3 Global DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 4 Global DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 5 Global DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 6 Global DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 7 Global DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 8 North America DNA sequencing market, by country, 2018 - 2030 (USD Million)
Table 9 North America DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 10 North America DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 11 North America DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 12 North America DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 13 North America DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 14 U.S. DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 15 U.S. DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 16 U.S. DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 17 U.S. DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 18 U.S. DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 19 Canada DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 20 Canada DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 21 Canada DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 22 Canada DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 23 Canada DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 24 Europe DNA sequencing market, by country, 2018 - 2030 (USD Million)
Table 25 Europe DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 26 Europe DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 27 Europe DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 28 Europe DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 29 U.S. DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 30 Germany DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 31 Germany DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 32 Germany DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 33 Germany DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 34 Germany DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 35 UK DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 36 UK DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 37 UK DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 38 UK DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 39 UK DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 40 France DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 41 France DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 42 France DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 43 France DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 44 France DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 45 Italy DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 46 Italy DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 47 Italy DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 48 Italy DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 49 Italy DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 50 Spain DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 51 Spain DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 52 Spain DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 53 Spain DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 54 Spain DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 55 Denmark DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 56 Denmark DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 57 Denmark DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 58 Denmark DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 59 Denmark DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 60 Sweden DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 61 Sweden DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 62 Sweden DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 63 Sweden DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 64 Sweden DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 65 Norway DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 66 Norway DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 67 Norway DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 68 Norway DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 69 Norway DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 70 Asia Pacific DNA sequencing market, by country, 2018 - 2030 (USD Million)
Table 71 Asia Pacific DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 72 Asia Pacific DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 73 Asia Pacific DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 74 Asia Pacific DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 75 Asia Pacific DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 76 China DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 77 China DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 78 China DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 79 China DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 80 China DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 81 Japan DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 82 Japan DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 83 Japan DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 84 Japan DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 85 Japan DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 86 India DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 87 India DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 88 India DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 89 India DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 90 India DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 91 South Korea DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 92 South Korea DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 93 South Korea DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 94 South Korea DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 95 South Korea DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 96 Australia DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 97 Australia DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 98 Australia DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 99 Australia DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 100 Australia DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 101 Thailand DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 102 Thailand DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 103 Thailand DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 104 Thailand DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 105 Thailand DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 106 Latin America DNA sequencing market, by country, 2018 - 2030 (USD Million)
Table 107 Latin America DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 108 Latin America DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 109 Latin America DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 110 Latin America DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 111 Latin America DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 112 Brazil DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 113 Brazil DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 114 Brazil DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 115 Brazil DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 116 Brazil DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 117 Mexico DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 118 Mexico DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 119 Mexico DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 120 Mexico DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 121 Mexico DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 122 Argentina DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 123 Argentina DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 124 Argentina DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 125 Argentina DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 126 Argentina DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 127 MEA DNA sequencing market, by country, 2018 - 2030 (USD Million)
Table 128 MEA DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 129 MEA DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 130 MEA DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 131 MEA DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 132 MEA DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 133 South Africa DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 134 South Africa DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 135 South Africa DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 136 South Africa DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 137 South Africa DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 138 Saudi Arabia DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 143 UAE DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 144 UAE DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 145 UAE DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 146 UAE DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 147 UAE DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 148 Kuwait DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 149 Kuwait DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 150 Kuwait DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 151 Kuwait DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 152 Kuwait DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 2 Global DNA sequencing market, by region, 2018 - 2030 (USD Million)
Table 3 Global DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 4 Global DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 5 Global DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 6 Global DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 7 Global DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 8 North America DNA sequencing market, by country, 2018 - 2030 (USD Million)
Table 9 North America DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 10 North America DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 11 North America DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 12 North America DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 13 North America DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 14 U.S. DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 15 U.S. DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 16 U.S. DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 17 U.S. DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 18 U.S. DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 19 Canada DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 20 Canada DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 21 Canada DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 22 Canada DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 23 Canada DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 24 Europe DNA sequencing market, by country, 2018 - 2030 (USD Million)
Table 25 Europe DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 26 Europe DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 27 Europe DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 28 Europe DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 29 U.S. DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 30 Germany DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 31 Germany DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 32 Germany DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 33 Germany DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 34 Germany DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 35 UK DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 36 UK DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 37 UK DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 38 UK DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 39 UK DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 40 France DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 41 France DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 42 France DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 43 France DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 44 France DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 45 Italy DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 46 Italy DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 47 Italy DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 48 Italy DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 49 Italy DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 50 Spain DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 51 Spain DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 52 Spain DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 53 Spain DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 54 Spain DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 55 Denmark DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 56 Denmark DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 57 Denmark DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 58 Denmark DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 59 Denmark DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 60 Sweden DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 61 Sweden DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 62 Sweden DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 63 Sweden DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 64 Sweden DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 65 Norway DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 66 Norway DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 67 Norway DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 68 Norway DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 69 Norway DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 70 Asia Pacific DNA sequencing market, by country, 2018 - 2030 (USD Million)
Table 71 Asia Pacific DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 72 Asia Pacific DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 73 Asia Pacific DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 74 Asia Pacific DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 75 Asia Pacific DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 76 China DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 77 China DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 78 China DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 79 China DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 80 China DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 81 Japan DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 82 Japan DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 83 Japan DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 84 Japan DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 85 Japan DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 86 India DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 87 India DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 88 India DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 89 India DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 90 India DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 91 South Korea DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 92 South Korea DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 93 South Korea DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 94 South Korea DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 95 South Korea DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 96 Australia DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 97 Australia DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 98 Australia DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 99 Australia DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 100 Australia DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 101 Thailand DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 102 Thailand DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 103 Thailand DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 104 Thailand DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 105 Thailand DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 106 Latin America DNA sequencing market, by country, 2018 - 2030 (USD Million)
Table 107 Latin America DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 108 Latin America DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 109 Latin America DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 110 Latin America DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 111 Latin America DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 112 Brazil DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 113 Brazil DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 114 Brazil DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 115 Brazil DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 116 Brazil DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 117 Mexico DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 118 Mexico DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 119 Mexico DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 120 Mexico DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 121 Mexico DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 122 Argentina DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 123 Argentina DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 124 Argentina DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 125 Argentina DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 126 Argentina DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 127 MEA DNA sequencing market, by country, 2018 - 2030 (USD Million)
Table 128 MEA DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 129 MEA DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 130 MEA DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 131 MEA DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 132 MEA DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 133 South Africa DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 134 South Africa DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 135 South Africa DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 136 South Africa DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 137 South Africa DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 138 Saudi Arabia DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 143 UAE DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 144 UAE DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 145 UAE DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 146 UAE DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 147 UAE DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 148 Kuwait DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
Table 149 Kuwait DNA sequencing market, by technology, 2018 - 2030 (USD Million)
Table 150 Kuwait DNA sequencing market, by application, 2018 - 2030 (USD Million)
Table 151 Kuwait DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 152 Kuwait DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 DNA sequencing market: market outlook
Fig. 9 DNA sequencing segment snapshot
Fig. 10 DNA sequencing competitive insights
Fig. 11 Parent market outlook
Fig. 12 DNA sequencing market driver impact
Fig. 13 DNA sequencing market restraint impact
Fig. 14 DNA sequencing market: Product & service outlook and key takeaways
Fig. 15 DNA sequencing market: Product & service movement analysis
Fig. 16 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 DNA sequencing market: technology outlook and key takeaways
Fig. 20 DNA sequencing market: technology movement analysis
Fig. 21 Sanger sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Next-Generation sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Whole Genome Sequencing (WGS) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Whole Exome Sequencing (WES) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Third generation sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Single-Molecule Real-Time Sequencing (SMRT) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Nanopore sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 DNA sequencing market: workflow outlook and key takeaways
Fig. 30 DNA sequencing market: workflow movement analysis
Fig. 31 Pre-sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Data analysis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 DNA sequencing market: application outlook and key takeaways
Fig. 35 DNA sequencing market: application movement analysis
Fig. 36 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Reproductive health market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Clinical investigation market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 39 Agrigenomics & forensics market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 40 HLA typing/immune system monitoring market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Metagenomics, epidemiology & drug development market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Consumer genomics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 DNA sequencing market: end-use outlook and key takeaways
Fig. 45 DNA sequencing market: end-use movement analysis
Fig. 46 Academic research market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Clinical research market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Hospitals & Clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Pharmaceutical & biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Other users market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Global DNA sequencing market: Regional movement analysis
Fig. 52 Global DNA sequencing market: Regional outlook and key takeaways
Fig. 53 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 UK market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Norway market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 China market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Japan market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 India market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 Australia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 UAE market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 DNA sequencing market: market outlook
Fig. 9 DNA sequencing segment snapshot
Fig. 10 DNA sequencing competitive insights
Fig. 11 Parent market outlook
Fig. 12 DNA sequencing market driver impact
Fig. 13 DNA sequencing market restraint impact
Fig. 14 DNA sequencing market: Product & service outlook and key takeaways
Fig. 15 DNA sequencing market: Product & service movement analysis
Fig. 16 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 DNA sequencing market: technology outlook and key takeaways
Fig. 20 DNA sequencing market: technology movement analysis
Fig. 21 Sanger sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Next-Generation sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Whole Genome Sequencing (WGS) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Whole Exome Sequencing (WES) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Third generation sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Single-Molecule Real-Time Sequencing (SMRT) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Nanopore sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 DNA sequencing market: workflow outlook and key takeaways
Fig. 30 DNA sequencing market: workflow movement analysis
Fig. 31 Pre-sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Data analysis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 DNA sequencing market: application outlook and key takeaways
Fig. 35 DNA sequencing market: application movement analysis
Fig. 36 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Reproductive health market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Clinical investigation market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 39 Agrigenomics & forensics market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 40 HLA typing/immune system monitoring market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Metagenomics, epidemiology & drug development market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Consumer genomics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 DNA sequencing market: end-use outlook and key takeaways
Fig. 45 DNA sequencing market: end-use movement analysis
Fig. 46 Academic research market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Clinical research market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Hospitals & Clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Pharmaceutical & biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Other users market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Global DNA sequencing market: Regional movement analysis
Fig. 52 Global DNA sequencing market: Regional outlook and key takeaways
Fig. 53 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 UK market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Norway market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 China market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Japan market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 India market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 Australia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 UAE market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Companies Mentioned
- Thermo Fisher Scientific, Inc
- Agilent Technology
- Illumina, Inc.
- QIAGEN
- F. Hoffmann-La Roche Ltd.
- Oxford Nanopore Technologies plc.
- Macrogen, Inc.
- PerkinElmer Genomics
- PacBio
- BGI
- Bio-Rad Laboratories, Inc.
- Myriad Genetics
- PierianDx
- Partek Incorporated
- Eurofins Scientific
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 130 |
| Published | February 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 12.39 Billion |
| Forecasted Market Value ( USD | $ 48.22 Billion |
| Compound Annual Growth Rate | 21.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
